Once-yearly injectable PrEP and once-monthly prevention pills are now in late-stage trials.
Twice-yearly injectable lenacapavir (Yeztugo) has been hailed as a breakthrough in HIV prevention, but a once-yearly formulation could have an even greater impact on the epidemic. And for people who prefer pills, once-monthly MK-8527 pre-exposure …